Clenbuterol/KLH is an antigen-adjuvant conjugate of Clenbuterol and keyhole limpet hemocyanin (KLH). Conjugating the antigen with a protein adjuvant enhances the production of antigen-specific antibodies in vaccine models. This conjugate does not disrupt protein folding or primary epitopes and improves cross-presentation and antigen-specific T cell generation.